Mylan, maker of lifesaving Epipen, raises price from <$100 in '07, to $608.61 5/16. In same period, CEO compensation goes from $2,453,456, to $18,931,068. 2/16, company moves legal home to Netherlands for tax inversion. What Mylan & CEO are doing is:
Show of Hands
Comments: Add Comment